Benefits Of Using Preferred Providers For Clinical Development Outsourcing

In Q1 2018, ISR surveyed 117 outsourcers at biopharmaceutical sponsors regarding the use and performance of a variety of clinical development outsourcing models. According to respondents using the Preferred Provider model, the most frequently experienced benefits of employing this model include Improved service provider relationships/deeper partnerships (mentioned by 60% of respondents) and Vendor consolidation (59% of respondents). The most oft-mentioned drawback is Lack of ultimate control (41% of respondents) with several others close behind.